Application of benzo(a)pyrene and coal tar tumor dose-response data to a modified benchmark dose method of guideline development

Environmental Health Perspectives

Volumn 112, Issue 14, 2004, Pages 1341-1346

  Fitzgerald, D James ^a   Robinson, Neville I ^b,c   Pester, Beverly A ^a  

^a Environmental Health Service   (Australia)

^b CSIRO   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

7 H benzo(c)fluorene; Benzo(a)pyrene; Cancer risk assessment; Dose response modeling; Modified benchmark dose method; PAH; Soil carcinogens

Indexed keywords

BENZO[A]PYRENE; COAL TAR; FLUORENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; DECISION MAKING; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; LIFESPAN; LUNG TUMOR; MATHEMATICAL MODEL; MOUSE; NONHUMAN; POLICY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SAFETY; STATISTICAL MODEL; STOMACH TUMOR;

ANIMALS; BENCHMARKING; BENZO(A)PYRENE; CARCINOGENS, ENVIRONMENTAL; COAL TAR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; GUIDELINES; HUMANS; KERATOLYTIC AGENTS; MODELS, THEORETICAL; NEOPLASMS; POLICY MAKING; RISK ASSESSMENT;

ANIMALIA;

EID: 6344258983     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6427     Document Type: Article

References (48)

1. Abdel-Rahman MS, Skowronski GA, Turkall RM. 2002. Assessment of the dermal bioavailability of soil-aged benzo(a)pyrone. Human Ecol Risk Assess 8:429-441.
2. ANZECC and NHMRC. 1992. Australian and New Zealand Guidelines for the Assessment and Management of Contaminated Sites. Canberra, Australia:Australia and New Zealand Environment Conservation Council, and National Health and Medical Research Council.
3. Boffetta P, Jourenkova N, Gustavsson P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444-472.
4. Bordelon NR, Donnelly KC, King LC, Wolf DC, Reeves WR, George SE. 2000. Bioavailability of the genotoxic components in coal tar contaminated soils in Fischer 344 rats. Toxicol Sci 56:37-48.
5. Boström C-E, Gerde P, Hanberg A, Jernström B, Johansson C, Kyrklund T, et al. 2002. Cancer risk assessment, indicators and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110(suppl 3):451-489.
6. Boyd HB, Pederson F, Cohr K-H, Damborg A, Jakobsen BM, Kristensen P, et al, 1999. Exposure scenarios and guidance values for urban soil pollutants. Regul Toxicol Pharmacol 30:197-208.
7. Brune H, Deutsch-Wenzel RP, Habs M, Ivankovic S, Schmähl D. 1981. Investigation of the tumorigenic response to benzo(a pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J Cancer Res Clin Oncol 102:153-157.
8. Crump K. 1984. A now method for determining allowable daily intakes. Fundam Appl Toxicol 4:854-891.
9. Crump K. 1995. Calculation of benchmark doses from continuous data. Risk Anal 15:79-89.
10. Culp SJ , Gaylor DW, Winslow GS, Goldstein LS, Beland FA. 1998. A comparison of the tumors induced by coal tar and benzo[a pyrene in a 2-year bioassay. Carcinogenesis 19(4):117-124.
11. Culp SJ, Warbritton AR, Smith BA, Li EE, Beland FA. 2000. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo(a pyrene. Carcinogenesis 21:1433-1440.
12. Dourson ML, Felter SP, Robinson D. 1996. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol 24:108-120.
13. Fitzgerald DJ. 1991. Setting response levels for polycyclic aromatic hydrocarbons (PAHs). In: The Health Risk Assessment and Management of Contaminated Sites (El Saadi O, Langley A, eds). Adelaide, Australia:South Australian Health Commission, 153-161.
14. Fitzgerald DJ. 1993. Carcinogenic soil contaminants: an Australian approach, ln: The Health Risk Assessment and Management of Contaminated Sites II (Langley A, van Alphen M, eds). Contaminated Sites Monograph No. 2. Adelaide, Australia:South Australian Health Commission, 51-64.
15. Fitzgerald J. 1998. The benchmark dose approach and health-based investigation level for polycyclic aromatic hydrocarbons (PAHs). In: The Health Risk Assessment and Management of Contaminated Sites IV (Langley A, Imray P, Lock W, Hill H, eds). Contaminated Sites Monograph No. 7. Adelaide, Australia:South Australian Health Commission, 81-92.
16. Gargas ML, Finley BL, Paustenbach DJ, Long TF. 2000. Environmental health risk assessment: theory and practice. In: General and Applied Toxicology (Ballantyne B, Marrs TC, Syversen T, eds). 2nd ad. London:Macmillan, 1749-1809.
17. Gaylor DW, Culp SJ, Goldstein LS, Beland FA. 2000. Cancer risk estimation for mixtures of coal tar and benzo(a)pyrene. Risk Anal 20:81-85.
18. Gaylor DW, Moolgavkar S, Krewski D, Goldstein LS. 1998. Recent bioassay results on coal tars and benzo(a)pyrene: implications for risk assessment. Regul Toxicol Pharmacol 28:178-179.
19. Goldstein LS. 2001. To BaP or not to BaP? That is the question [Editorial]. Environ Health Perspect 109:A356-A357.
20. Goldstein LS, Weyand EH, Safe S, Steinberg M, Culp SJ, Gaylor DW, et al. 1998. Tumors and DNA adducts in mice exposed to benzo[a pyrene and coal tars: implications for risk assessment. Environ Health Perspect 106(suppl 6):1325-1330.
21. Hengstler JG, Van der Burg B, Steinberg P, Oesch F. 1999. Interspecies differences in cancer susceptibility and toxicity. Drug Metab Rev 31:917-970.
22. Hsu IC, Harris CC, Lipsky MM, Snyder S, Trump BF. 1987. Cell and species differences in metabolic activation of chemical carcinogens. Mutat Res 177:1-7.
23. IARC. 1987. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. Monogr Eval Carcinog Risks Hum (Suppl 7).
24. Kazerouni N, Sinha R, Hsu C-H, Greenberg A, Rothman N. 2001. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 39:423-436.
25. Khalili NR, Thomas S. 2001. Application of lung deposition model in carcinogenic risk assessment of polyaromatic hydrocarbons. Environ Health 1:18-31.
26. Koganti A, Singh R, Ma B-L, Weyand EH. 2001. Comparative analysis of PAH:DNA adducts formed in lung of mice exposed to neat coal tar and soils contaminated with coal tar. Environ Sci Technol 35:2704-2709.
27. Koganti A, Singh R, Rozett K, Modi N, Goldstein LS, Roy TA, et al. 2000. 7H-benzo[c]fluorene: a major DNA adduct-forming component of coal tar. Carcinogenesis 21:1601-1609.
28. Kroese ED, Muller JJA, Mohn GR, Dortant PM, Wester PW. 2001. Tumorigenic Effects in Wistar Rats Orally Administered Benzo[a pyrene for Two Years (Gavage Studies). Implications for Human Cancer Risks Associated with Oral Exposure to Polycyclic Aromatic Hydrocarbons. RIVM Report no. 658603010. Bilthoven, Netherlands:National Institute of Public Health and the Environment.
29. Larsen JC, Larsen PB. 1998. Chemical carcinogens. In: Air Pollution and Health (Hester RE, Harrison RM, eds). Cambridge, UK:Royal Society of Chemistry, 33-56.
30. Lewis SC, Lynch JR, Nikiforov AI. 1990. A new approach to deriving community exposure guidelines from " no-observed-adverse-effect levels." Regul Toxicol Pharmacol 11:314-330.
31. National Environment Protection Council. 1999. National Environment Protection (Assessment of Site Contamination) Measure 1999: Schedule B (7a) Guideline on Health-Based Investigation Levels. National Environmental Health Forum Monographs. Soil Series No. 1. 3rd ed. Available: http://www.ephc.gov.au/pdf/cs/cs_07a_health_based_inv.pdf [accessed 23 July 2004].
32. Neal J, Rigdon RH. 1967. Gastric tumors in mice fed benzo[ a]pyrene: a quantitative study. Texas Rep Biol Med 25:553-557.
33. NHMRC. 1999. Toxicity Assessment for Carcinogenic Soil Contaminants. Canberra, Australia:National Health and Medical Research Council. Available: http://www.health.gov.au:80/nhmrc/publications/synopses/eh21syn.htm [accessed 9 June 2004].
34. Nisbet ICT, LaGoy PK. 1992. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regul Toxicol Pharmacol 16:290-300.
35. Oesch F, Raphael D, Schwind H, Glatt HR. 1977. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites. Arch Toxicol 39:97-108.
36. Reeves WR, McDonald TJ, Bordelon NR, George SE, Donnelly KC. 2001. Impacts of aging on in vivo and in vitro measurements of soil-bound polycyclic aromatic hydrocarbon availability. Environ Sci Technol 35:1637-1643.
37. 32P-postlabeling analysis of benzo[a]pyrene-DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes. Carcinogenesis 14:1945-1950.
38. RPS. 1995. Contaminants in Soil: Collation of Toxicological Data and Intake Values for Humans. Polycyclic Aromatic Hydrocarbons. Project No. EPC/1/6/11. Report to the U.K. Department of the Environment. London:RPS.
39. Rubin H. 2001. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 22:1903-1930.
40. Stanek EJ III, Calabrese EJ. 2000. Daily soil ingestion estimates for children at a Superfund site. Risk Anal 20:627-635.
41. U.S. EPA. 1980. Ambient Water Duality Criteria for Polynuclear Aromatic Hydrocarbons. EPA-440/5-80-069. Washington, DC:U.S. Environmental Protection Agency.
42. U.S. EPA. 1995. The Use of the Benchmark Dose Approach in Health Risk Assessment. Risk Assessment Forum. EPA/630/R-94-007. Washington, DC:U.S. Environmental Protection Agency.
43. U.S. EPA. 2003. Benchmark Dose Software. Washington, DC:U.S. Environmental Protection Agency. Available: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm [accessed 9 September 2003].
44. Wang JQ, Weyand EH, Harvey RG. 2002. Synthesis of suspected carcinogenic metabolites of 7H-benzo[c]fluorene, a coal tar component implicated in causation of lung tumors. J Org Chem 67:6216-6219.
45. Weyand EH, Chen Y-C, Wu Y, Koganti A, Dunsford HA, Rodriguez LV. 1995. Differences in the tumorigenic activity of a pure hydrocarbon and a complex mixture following ingestion: benzo(a)pyrene vs manufactured gas plant residue. Chem Res Toxicol 8:949-954.
46. Weyand EH, Goldstein LS, Reuhl KR, Wang JQ, Harvey RG. 2002. Induction of lung tumors by 7H-benzo[c]fluorene [Abstract]. Toxicologist 61:909.
47. Weyand EH, Wu Y. 1995. Covalent binding of polycyclic aromatic hydrocarbon components of manufactured gas plant residue to mouse lung and forestomach DNA. Chem Res Toxicol 8:955-962.
48. WHO. 1994. Guidance Values for Human Exposure Limits. Environmental Health Criteria 170. Geneva:International Programme on Chemical Safety, World Health Organization.